Journal of Psychiatric Research
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Predictors of illicit substance abuse/dependence during young adulthood: A machine learning approach
2023
-
Biologic validation of diagnoses of depression
1981
-
The effect of weighted blankets on sleep quality and mental health symptoms in people with psychiatric disorders in inpatient and outpatient settings: A systematic review and meta-analysis..
179:286-294.
2024
-
Active suicidal ideation associated with dysfunction in default mode network using resting-state EEG and functional MRI - Findings from the T-RAD Study.
176:240-247.
2024
-
Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: A systematic review.
175:287-315.
2024
-
Premorbid intelligence quotient and school failure as risk markers for bipolar disorder and major depressive disorder.
169:160-165.
2024
-
High-resolution examination of changes in drinking during the COVID-19 pandemic: Nine-wave findings from a longitudinal observational cohort study of community adults.
168:249-255.
2023
-
Who really hoards? Hoarding symptoms in adults with attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD) and healthy controls.
166:74-79.
2023
-
Practices, knowledge, and attitudes about lithium treatment: Results of online surveys completed by clinicians and lithium-treated patients.
164:335-343.
2023
-
The comorbidity between Borderline Personality Disorder (BPD) and Generalized Anxiety Disorder (GAD): A systematic review and meta-analysis.
164:304-314.
2023
-
Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies.
162:44-56.
2023
-
The HARM models: Predicting longitudinal physical aggression in patients with schizophrenia at an individual level.
161:91-98.
2023
-
Triggers for acute mood episodes in bipolar disorder: A systematic review.
161:237-260.
2023
-
Functional assessment short test (FAST): Self-administration in outpatient mental health settings.
160:258-262.
2023
-
Childhood trauma, inflammatory biomarkers and the presence of a current depressive episode: Is there a relationship in subjects from a population study?.
158:255-260.
2023
-
Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjects.
157:152-161.
2023
-
Cannabis use in Attention – Deficit/Hyperactivity Disorder (ADHD): A scoping review.
157:239-256.
2023
-
Does cannabis use impact cognitive behavioural therapy outcomes for anxiety and related disorders? A preliminary examination.
156:690-697.
2022
-
Obsessive-compulsive disorder during the COVID-19 pandemic.
149:114-123.
2022
-
Public perceptions of psychiatric, justice-involved, and elderly populations during the COVID-19 pandemic.
146:67-76.
2022
-
Substance use as a risk factor for bipolar disorder: A systematic review.
144:285-295.
2021
-
Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study.
142:321-327.
2021
-
Impact of peritraumatic dissociation in hospitalized patients with COVID-19 pneumonia: A longitudinal study.
140:53-59.
2021
-
Prevalence and correlates of current suicide risk in an international sample of OCD adults: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacology.
140:357-363.
2021
-
Predicting offenses among individuals with psychiatric disorders - A machine learning approach.
138:146-154.
2021
-
Anxiety, depression and stress during the COVID-19 pandemic: Results from a cross-sectional survey.
137:96-103.
2021
-
Transcriptional markers of excitation-inhibition balance in germ-free mice show region-specific dysregulation and rescue after bacterial colonization.
135:248-255.
2021
-
Clozapine in bipolar disorder: A systematic review and meta-analysis.
125:21-27.
2020
-
Effects of interventions to reduce adolescent depression in low- and middle-income countries: A systematic review and meta-analysis.
123:201-215.
2020
-
Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics.
119:33-47.
2019
-
Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder.
118:1-6.
2019
-
Anxiety disorders in childhood are associated with youth IL-6 levels: A mediation study including metabolic stress and childhood traumatic events.
115:43-50.
2019
-
Association between solar insolation and a history of suicide attempts in bipolar I disorder.
113:1-9.
2019
-
Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users.
111:134-139.
2019
-
Volumetric brain magnetic resonance imaging predicts functioning in bipolar disorder: A machine learning approach.
103:237-243.
2018
-
Oxidative stress markers imbalance in late-life depression.
102:29-33.
2018
-
The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study.
102:186-191.
2018
-
GWAS-based machine learning approach to predict duloxetine response in major depressive disorder.
99:62-68.
2018
-
Time distortion when users at-risk for social media addiction engage in non-social media tasks.
97:84-88.
2018
-
Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: Population-based study.
92:119-123.
2017
-
Mood disorders and biological rhythms in young adults: A large population-based study.
84:98-104.
2017
-
The use of waitlists as control conditions in anxiety disorders research.
83:112-120.
2016
-
Hippocampal volume and verbal memory performance in late-stage bipolar disorder.
73:102-107.
2016
-
Memory and brain-derived neurotrophic factor after subchronic or chronic amphetamine treatment in an animal model of mania.
68:329-336.
2015
-
Influence of light exposure during early life on the age of onset of bipolar disorder.
64:1-8.
2015
-
READMIT: A clinical risk index to predict 30-day readmission after discharge from acute psychiatric units.
61:205-213.
2015
-
Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF.
59:8-13.
2014
-
Inflammatory mediators of cognitive impairment in bipolar disorder.
56:18-27.
2014
-
BDNF: A biomarker for social vulnerability in individuals diagnosed with gender dysphoria.
50:16-17.
2014
-
Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults.
48:13-15.
2014
-
Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
47:1396-1402.
2013
-
Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder.
47:1546-1548.
2013
-
Childhood and family influences on depression, chronic physical conditions, and their comorbidity: Findings from the Ontario Child Health Study.
46:1475-1482.
2012
-
Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder.
46:1511-1514.
2012
-
Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
46:819-824.
2012
-
Neurobiological correlates of illness progression in the recurrent affective disorders.
46:561-573.
2012
-
Increased levels of adipokines in bipolar disorder.
46:389-393.
2012
-
Re.Test-retest reliability problems in Schaller et al. (2011) rTMS results.
46:412-412.
2012
-
Systemic toxicity in early-stage mood disorders.
45:1407-1409.
2011
-
Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis.
45:995-1004.
2011
-
Childhood adversity and personality disorders: Results from a nationally representative population-based study.
45:814-822.
2011
-
Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls.
45:495-504.
2011
-
Peripheral biomarkers and illness activity in bipolar disorder.
45:156-161.
2011
-
Peripheral biomarkers and illness activity in bipolar disorder.
45:156-161.
2011
-
Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.
44:1005-1009.
2010
-
Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
44:903-909.
2010
-
Impairment of the mitochondrial electron transport chain due to sleep deprivation in mice.
44:775-780.
2010
-
Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
44:700-706.
2010
-
Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes.
44:561-565.
2010
-
Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
44:506-510.
2010
-
Association of polymorphisms of the tryptophan hydroxylase 2 gene with risk for bipolar disorder or suicidal behavior.
44:271-274.
2010
-
The relationship of gambling to intimate partner violence and child maltreatment in a nationally representative sample.
44:331-337.
2010
-
Functional impact of biological rhythm disturbance in bipolar disorder.
44:220-223.
2010
-
Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis.
43:1200-1204.
2009
-
Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients.
43:1171-1174.
2009
-
Increased serum neurotrophin-4/5 levels in bipolar disorder.
43:721-723.
2009
-
Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.
42:416-421.
2008
-
Serum S100B and antioxidant enzymes in bipolar patients.
41:523-529.
2007
-
Anorexia nervosa in the male: Clinical features and follow-up of nine patients.
19:315-321.
1985
-
Visual information processing and alpha blocking in schizophrenics and normals.
16:95-102.
1981
-
A re-evaluation of glucose tolerance in schizophrenia..
6:261-270.
1969
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)